Boothbay Fund Management, LLC Adma Biologics, Inc. Transaction History

Boothbay Fund Management, LLC

$3.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.98 - $11.18 $1.76 Million - $3.28 Million	-293,496 Reduced 37.3%	493,311 $5.52 Million
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $1.33 Million - $2.04 Million	-302,899 Reduced 27.8%	786,807 $5.19 Million
Q4 2023 Feb 14, 2024	BUY	$3.08 - $4.52 $137,041 - $201,112	44,494 Added 4.26%	1,089,706 $4.93 Million
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $108,871 - $144,638	31,375 Added 3.09%	1,045,212 $3.74 Million
Q2 2023 Aug 14, 2023	SELL	$3.12 - $4.22 $688,481 - $931,214	-220,667 Reduced 17.87%	1,013,837 $3.74 Million
Q1 2023 May 15, 2023	BUY	$3.01 - $3.87 $551,188 - $708,670	183,119 Added 17.42%	1,234,504 $4.09 Million
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $17.5 Million - $27.4 Million	-7,069,768 Reduced 87.05%	1,051,385 $4.08 Million
Q3 2022 Nov 14, 2022	SELL	$2.03 - $2.86 $4.55 Million - $6.4 Million	-2,239,247 Reduced 21.61%	8,121,153 $19.7 Million
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $68,438 - $105,289	-47,859 Reduced 0.46%	10,360,400 $20.5 Million
Q1 2022 May 16, 2022	BUY	$1.28 - $1.83 $2.72 Million - $3.89 Million	2,124,399 Added 25.65%	10,408,259 $19 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $5.62 Million - $8.55 Million	5,153,324 Added 164.61%	8,283,860 $11.7 Million
Q3 2021 Nov 15, 2021	BUY	$1.13 - $1.65 $3.28 Million - $4.79 Million	2,903,067 Added 1276.25%	3,130,536 $3.54 Million
Q2 2021 Aug 16, 2021	BUY	$1.51 - $2.07 $36,821 - $50,476	24,385 Added 12.01%	227,469 $364,000
Q1 2021 May 17, 2021	BUY	$1.67 - $2.95 $99,446 - $175,669	59,549 Added 41.49%	203,084 $357,000
Q4 2020 Feb 12, 2021	BUY	$1.8 - $2.56 $96,215 - $136,839	53,453 Added 59.34%	143,535 $280,000
Q3 2020 Nov 16, 2020	BUY	$2.04 - $3.74 $3,227 - $5,916	1,582 Added 1.79%	90,082 $215,000
Q2 2020 Aug 14, 2020	SELL	$2.42 - $3.29 $150,628 - $204,779	-62,243 Reduced 41.29%	88,500 $259,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.59 $226,114 - $691,910	150,743 New	150,743 $434,000

Others Institutions Holding ADMA

# of Institutions

319

Shares Held

185M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.91B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Account